Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results

$1,790,993 $1,511,956

Adjustments to reconcile net income to

net cash provided by (used in) operating


Depreciation and amortization 119,399 81,486

Changes in current assets and

current liabilities:

Accounts receivable (88,138) 7,982

Inventory (1,019,969) 285,546

Other receivables (339,566) (159,635)

Advances to suppliers -- (397,200)

Other current assets 152,822 --

Accounts payable and accrued expenses (60,470) (277,424)

VAT taxes payable (15,780) (40,499)

Income tax payable 16,489 (42,565)

Payroll taxes payable (22,708) --

Other current liabilities (29,277) 77,928

Total adjustments: (1,287,198) (464,381)

Net cash provided by

operating activities: 503,795 1,047,575

Cash flows from investing activities:

Additions to property and equipment -- (713)

Additions to intangibles (175,668) --

Net cash used in investing

activities: (175,668) (713)

Cash flows from financing activities:

Additional paid-in capital -- 8,000

Issuance of preferred stock -- 140,207

Repayment of short-term bank loans -- (794,760)

Repayment of long-term bank loans -- (120,541)


SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
2. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
3. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
4. Tianyin Pharmaceutical Appoints Three New Independent Board Members
5. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
6. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
7. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
8. Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research
9. Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction
10. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
11. Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call
Post Your Comments:
(Date:7/31/2014)... July 31, 2014 Research and Markets ... Genomics Market 2014-2018" report to their offering. ... is the study of the genetic material or genomes ... strong basis for the discovery and development of diagnostic ... or health conditions. Genomics is supported by three major ...
(Date:7/31/2014)... Francisco, Calif. (PRWEB) July 31, 2014 ... newly diagnosed patients with an overview of the disease ... management of drug side effects, as well as updates ... “We’re grateful to Dr. Sandy Srinivas for organizing this ... survivor of kidney cancer. “Sandy and her colleagues have ...
(Date:7/31/2014)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ... clinical grade hypothermic storage and cryopreservation ... for cells and tissues, today announced today that ... released on Thursday, August 7, 2014, and that the ... at 4:30 p.m. ET that afternoon. Management will provide ...
(Date:7/30/2014)... JOLLA, Calif. , July 30, 2014 ... ), a biopharmaceutical company leading the discovery and development ... will report financial results and highlights for the quarter ... after the U.S. financial markets close. ... Wednesday, August 6, 2014, at 5:00 pm Eastern Daylight ...
Breaking Biology Technology:Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... LOUIS, Sept. 1, 2011 /PRNewswire-iReach/ -- Advanced Technological ... part by the National Science Foundation , returns with ... year. ATETV.ORG is a free Web video series ... high-tech education and employment opportunities. The series debuted ...
... CITY, Sept. 1, 2011 Asmacure Ltee, a ... nicotinic receptor agonists for the treatment of asthma ... Martin Driscoll will present at the 2011 BioPharm ... will provide an overview of Asmacure,s nicotinic acetylcholine ...
... BRUSSELS, September 1, 2011 The current ... successful research into blood-related diseases must ensure the safety ... This was a key message of a ... by the European Parliament and attended by doctors, researchers, ...
Cached Biology Technology:New Videos Spotlight Science/Technology Careers and Educational Path To Secure Jobs in Them 2Asmacure Ltee to Present at the 2011 BioPharm America Conference 2Crucial Directives Must be Revised to Protect Patients' Interests and Improve Access to Treatment 2
(Date:7/31/2014)... the largest minority group in the United States, comprising ... are obese and are 1.2 times as likely to ... College of Nursing student researcher Lauren Gerchow, BSN, RN, ... contribute to this problem by compiling a systematic review ... Latina women recently published in Nursing Research . ...
(Date:7/31/2014)... researchers have completed a 20-year study that looks ... at different times of the year. It finds ... time frame has no measurable negative consequences for ... benefits. , The study was conducted by Gene ... Station fire chief, and Joseph Craine, research assistant ...
(Date:7/31/2014)... noise alters how the brain processes speech, potentially ... to neuroscientists at The University of Texas at ... in Ear and Hearing , researchers demonstrated ... affects the brain,s recognition of speech sounds. , ... the population, affecting an estimated 15 percent of ...
Breaking Biology News(10 mins):NYU research looks to combat US Latina immigrant obesity 2Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3UT Dallas study reveals effect of loud noises on brain 2
... of Central Florida researcher may have found a defense against ... of Europe,s population in the Middle Ages and which government ... Professor Henry Daniell and his team have developed a vaccine ... Findings of his National Institutes of Health and USDA funded ...
... cold is not only uncomfortable, it can be deadlycausing ... years now, scientists have understood the molecular mechanisms that ... high temperatures that directly trigger heat sensor proteins known ... is how animals sense very small temperature differences in ...
... stem cell technology are among the cutting-edge approaches ... J. Fox Foundation,s Rapid Response Innovation Awards 2008. ... treatments and a cure for PD, the Foundation ... Parkinson,s disease research projects under the initiative in ...
Cached Biology News:UCF professor develops vaccine to protect against black plague bioterror attack 2UCF professor develops vaccine to protect against black plague bioterror attack 3Summer heat too hot for you? What is comfortable? 2Summer heat too hot for you? What is comfortable? 3Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinson's Disease 2Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinson's Disease 3
... Y2 Receptor antiserum This NPY Y2 ... level and is currently being characerized in brain. ... and mouse and appears to work better on ... rat. For full characterizarion in dorsal root ganglion ...
RECK (F-20)...
Black Polypropylene 384 Round Well Plate 70/Box...
... 1 Peroxiredoxin (Prx) is a ... have been known to connect with ... isoforms (about 50 proteins), collected in ... homology, particularly amino-terminal region containing active ...
Biology Products: